The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy
Open accessAbstract
Poor tumor penetration is a major challenge for the use of nanoparticles in anticancer therapy. Moreover, the inability to reach hypoxic tumor cells that are distant from blood vessels results in inadequate exposure to antitumor therapeutics and contributes to development of chemoresistance and increased metastasis. In the present study, we developed iRGD-modified nanoparticles for simultaneous tumor delivery of a photosensitizer indocyanine green (ICG) and hypoxia-activated prodrug tirapazamine (TPZ). The iRGD-modified nanoparticles loaded with ICG and TPZ showed significantly improved penetration in both 3D tumor spheroids in vitro and orthotopic breast tumors in vivo. ICG-mediated photodynamic therapy upon irradiation with a near-IR laser induced hypoxia, which activated antitumor activity of the codelivered TPZ for synergistic cell-killing effect. In vivo studies demonstrated that the nanoparticles could efficiently deliver the drug combination in 4T1 orthotopic tumors. Primary tumor growth and metastasis were effectively inhibited by the iRGD-modified combination nanoparticles with minimal side effects. The results also showed the anticancer benefits of codelivering ICG and TPZ in a single nanoparticle formulation in contrast to a mixture of nanoparticles containing individual drugs. The study demonstrates the benefits of combining tumor-penetrating nanoparticles with hypoxia-activated drug treatment and establishes a delivery platform for PDT and hypoxia-activated chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Drug combination studies and their synergy quantification using the Chou-Talalay method
Chou, T.-C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1947 · Cited by 5,739
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers
Idris, N. M., Gnanasammandhan, M. K., Zhang, J., Ho, P. C., Mahendran, R., & Zhang, Y. (2012) · Nature Medicine · doi:10.1038/nm.2933 · Cited by 1,464
The Pancreas Cancer Microenvironment
Feig, C., Gopinathan, A., Neesse, A., Chan, D. S., Cook, N., & Tuveson, D. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3114 · Cited by 1,316
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,075
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F. X., Rhee, J.-W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,038
Chen, Q., Feng, L., Liu, J., Zhu, W., Dong, Z., Wu, Y., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201601902 · Cited by 1,034
Cheng, Y., Cheng, H., Jiang, C., Qiu, X., Wang, K., Huan, W., Yuan, A., Wu, J., & Hu, Y. (2015) · Nature Communications · doi:10.1038/ncomms9785 · Cited by 941
Semiconductor Quantum Dots for Photodynamic Therapy
Samia, A. C. S., Chen, X., & Burda, C. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0386905 · Cited by 813
Chen, H., Tian, J., He, W., & Guo, Z. (2015) · Journal of the American Chemical Society · doi:10.1021/ja511420n · Cited by 813
Zheng, M., Yue, C., Ma, Y., Gong, P., Zhao, P., Zheng, C., Sheng, Z., Zhang, P., Wang, Z., & Cai, L. (2013) · ACS Nano · doi:10.1021/nn400334y · Cited by 795
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533
Zhang, C., Zhao, K., Bu, W., Ni, D., Liu, Y., Feng, J., & Shi, J. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201408472 · Cited by 516
Zhu, L., Kate, P., & Torchilin, V. P. (2012) · ACS Nano · doi:10.1021/nn300524f · Cited by 489
Manzoor, A. A., Lindner, L. H., Landon, C. D., Park, J.-Y., Simnick, A. J., Dreher, M. R., Das, S., Hanna, G., Park, W., Chilkoti, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1683 · Cited by 459
Tumor penetrating peptides for improved drug delivery
Ruoslahti, E. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.008 · Cited by 459
Liu, Y., Liu, Y., Bu, W., Cheng, C., Zuo, C., Xiao, Q., Sun, Y., Ni, D., Zhang, C., Liu, J., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500478 · Cited by 425
Feng, L., Cheng, L., Dong, Z., Tao, D., Barnhart, T. E., Cai, W., Chen, M., & Liu, Z. (2017) · ACS Nano · doi:10.1021/acsnano.6b07525 · Cited by 424
Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies
Brown, J. M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01677-4 · Cited by 350
Ogawa, M., Kosaka, N., Choyke, P. L., & Kobayashi, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3116 · Cited by 326
Fingar, V. H., Wieman, T. J., Wiehle, S., & Cerrito, P. B. (1992) · PubMed · Cited by 289
Gupta, M. K., Martin, J. R., Werfel, T. A., Shen, T., Page, J. M., & Duvall, C. L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja507626y · Cited by 262
Yu, H., Cui, Z., Yu, P., Guo, C., Feng, B., Jiang, T., Wang, S., Yin, Q., Zhong, D., Yang, X., et al. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201404484 · Cited by 253
Localized Electric Field of Plasmonic Nanoplatform Enhanced Photodynamic Tumor Therapy
Li, Y., Wen, T., Zhao, R., Liu, X., Ji, T., Wang, H., Shi, X., Shi, J., Wei, J., Zhao, Y., et al. (2014) · ACS Nano · doi:10.1021/nn5047647 · Cited by 239
Tian, J., Cheng, N., Liu, Q., Xing, W., & Sun, X. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201501237 · Cited by 228
Fang, R. H., Aryal, S., Hu, C.-M. J., & Zhang, L. (2010) · Langmuir · doi:10.1021/la103576a · Cited by 206
Barth, B. M., I. Altinoğlu, E., Shanmugavelandy, S. S., Kaiser, J. M., Crespo-Gonzalez, D., DiVittore, N. A., McGovern, C., Goff, T. M., Keasey, N. R., Adair, J. H., et al. (2011) · ACS Nano · doi:10.1021/nn2005766 · Cited by 178
Ma, M., Huang, Y., Chen, H., Jia, X., Wang, S., Wang, Z., & Shi, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.001 · Cited by 174
Tirapazamine: a novel agent targeting hypoxic tumor cells
Reddy, S. B., & Williamson, S. K. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802567250 · Cited by 161
Liu, Y., Zhang, D., Qiao, Z., Qi, G., Liang, X., Chen, X., & Wang, H. (2015) · Advanced Materials · doi:10.1002/adma.201501502 · Cited by 157
Peng, Z., & Kopec̆ek, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b00922 · Cited by 151
Self-citationSu, S., Tian, Y., Li, Y., Ding, Y., Ji, T., Wu, M.-Y., Wu, Y. F., & Nie, G. (2015) · ACS Nano · doi:10.1021/nn505729m · Cited by 132
Wang, T., Zhang, L., Su, Z., Wang, C., Liao, Y., & Fu, Q. (2011) · ACS Applied Materials & Interfaces · doi:10.1021/am200364e · Cited by 119
Tirapazamine: a hypoxia-activated topoisomerase II poison.
Peters, K. B., & Brown, J. M. (2002) · PubMed · Cited by 117
Gallagher, W. M., Allen, L. T., O'Shea, C., Kenna, T., Hall, M. J., Gorman, A., KILLORAN, J. J., & O’Shea, D. F. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602527 · Cited by 114
Busch, T. M., Hahn, S. M., Evans, S. M., & Koch, C. J. (2000) · PubMed · Cited by 113
Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia
Denny, W. A., & Wilson, W. R. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.12.2889 · Cited by 104
Hypoxia-directed and activated theranostic agent: Imaging and treatment of solid tumor
Kumar, R., Kim, E. J., Han, J., Lee, H., Shin, W. S., Kim, H. M., Bhuniya, S., Kim, J. S., & Hong, K. S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.010 · Cited by 102
Liu, Y., Liu, Y., Bu, W., Cheng, C., Zuo, C., Xiao, Q., Sun, Y., Ni, D., Zhang, C., Liu, J., et al. (2015) · Angewandte Chemie · doi:10.1002/ange.201500478 · Cited by 97
Cao, Y., Li, C.-Y., Moeller, B. J., Yu, D., Zhao, Y., Dreher, M. R., Shan, S., & Dewhirst, M. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4553 · Cited by 92
Akashi, Y., Oda, T., Ohara, Y., Miyamoto, R., Kurokawa, T., Hashimoto, S., Enomoto, T., Yamada, K., Satake, M., & Ohkohchi, N. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.49 · Cited by 90
Zhang, C., Zhao, K., Bu, W., Ni, D., Liu, Y., Feng, J., & Shi, J. (2014) · Angewandte Chemie · doi:10.1002/ange.201408472 · Cited by 72
Ni, D., Ding, H., Liu, S., Yue, H., Bao, Y., Wang, Z., Su, Z. G., Wei, W., & Ma, G. (2015) · Small · doi:10.1002/smll.201403632 · Cited by 63
Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy
Ding, Y., Wang, Y., Opoku‐Damoah, Y., Wang, C., Shen, L., Yin, L., & Zhou, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.051 · Cited by 56
Self-citationIntercapillary distance in the proliferating area of human glioma.
Yoshii, Y., & Sugiyama, K. (1988) · PubMed · Cited by 46
Bremner, J. C. M., Adams, G., Pearson, J., Sansom, J. M., Stratford, I. J., Bedwell, J., Bown, S. G., MacRobert, A. J., & Phillips, D. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.412 · Cited by 43
Lopez, X. M., Debeir, O., Maris, C., Rorive, S., Roland, I. H., Saerens, M., Salmon, I. J., & Decaestecker, C. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22085 · Cited by 36
Cited by
Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 830
Li, S.-Y., Cheng, H., Xie, B.-R., Qiu, W.-X., Zeng, J.-Y., Li, C.-X., Wan, S.-S., Zhang, L., Liu, W.-L., & Zhang, X.-Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b02533 · Cited by 780
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
Chen, J., Luo, H., Liu, Y., Zhang, W., Li, H., Luo, T., Zhang, K., Zhao, Y., & Liu, J. (2017) · ACS Nano · doi:10.1021/acsnano.7b08225 · Cited by 451
Bridging Bio–Nano Science and Cancer Nanomedicine
Björnmalm, M., Thurecht, K. J., Michael, M., Scott, A. M., & Caruso, F. (2017) · ACS Nano · doi:10.1021/acsnano.7b04855 · Cited by 382
Metadata
- Authors
- Wang, Y., Xie, Y., Li, J., Peng, Z.-H., Sheinin, Y., Zhou, J., & Oupický, D.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-02-06
- Volume
- 11
- Issue
- 2
- Pages
- 2227-2238
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2586840087
- Cited by
- 461
- References
- 53
- FWCI
- 24.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.